Gene Therapy for Neurologic Disease
Arch Neurol 50:1252-1268, Suhr,S.T.&Gage,F.H., 1993
Practice Parameter for Electrodiagnostic Studies in Carpal Tunnel Syndrome (Summary Statement)
AAN, et al, Neurol 43:2404-2405993., , 1993
Practice Parameter for Carpal Tunnel Syndrome (Summary Statement)
Quality Standards Subcommittee, AAN, Neurol 43:2406-2409993., , 1993
Time of Hospital Presentation in Patients with Acute Stroke
Arch Int Med 153:2558-2560, Barsan,W.G.,et al, 1993
Factors Associated with Early Presentation of Acute Stroke
Stroke 24:1805-1810, Feldmann,E.,et al, 1993
A Model for Management of Patients with Stroke During the Acute Phase Outcome and Economic Implications
Stroke 24:1823-1827, Odderson,I.R.&McKenna,B.S., 1993
Medicare Hospital Utilization Review for Ischemic Cerebrovascular Disease
Neurol 43:650-654, Lanska,D.J., 1993
Myocardial Infarction, Thrombolytic Therapy, and Stroke, A Community-Based Study
Stroke 24:587-590, Longstreth,W.T.,et al, 1993
Intracerebral Hemorrhage After Fibrinolytic Therapy for Acute Myocardial Infarction
C. R. , Stroke 24:554-557, 5233., Wijdicks,E.F.M.&Jack,Jr, 1993
Low Back Pain Associated with Anistreplase
BMJ 306:896, Lear,J.&Rajapakse,R., 1993
Questions People Ask About Stroke
Stroke 24:536-538, Hanger,H.C.&Mulley,G.P., 1993
Tinnitus:It's Causes, Diagnosis, and Treatment
BMJ 306:1490-1491, Luxon,L.M., 1993
Can Neurologists Survive or Thrive with Health Care Reform
Ann Neurol 33:441-444, Ringel,S.P., 1993
Gene Therapy for Duchenne Dystrophy
Ann Neurol 34:3-4, Engel,A.G., 1993
Myoblast Transfer in Duchenne Muscular Dystrophy
Ann Neurol 34:8-18, Karpati,G.,et al, 1993
Practice Parameters:Initial Therapy of Parkinson's Disease
Report of the Quality Standards Subcommittee of AAN, Neurol 43:1296-12971993., , 1993
Individual Risk Assessment for Intracranial Haemorrhage During Thrombolytic Therapy
Lancet 342:1523-1528, Simoons,M.L.,et al, 1993
Practice Guidelines in Neurology
Arch Neurol 49:193-195, Menken,M., 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Effects of Public and Professional Education on Reducing the Delay in Presentation and Referral of Stroke Patients
Stroke 23:352-356, Alberts,M.J.,et al, 1992
Should Patients with Alzheimer's Disease be Told Their Diagnosis
NEJM 326:947-951, Drickamer,M.A.&Lachs,M.S., 1992
Clinical Audit and Neurology
Hopkins. A. , JNNP 55 (Suppl) :19-25., , 1992
Cost-Effective Investigation of Patients with Suspected Transient Ischaemic Attacks
JNNP 55:171-176, Hankey,G.J.&Warlow,C.P., 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Intrinsic Spinal Cord Haemorrhage Due to Streptokinase Treatment for Myocardial Infarction
JNNP 55:740, Cruickshank,G.S.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Morphine Responsiveness of Chronic Pain:Double-Blind Randomized Crossover Study with Patinet-Controlled Analgesia
Lancet 339:1367-1371, Jadad,A.R.,et al, 1992
Clinical, Epidemiologic, & Virologic Studies in Four Clusters of the Chronic Fatigue Synd
Arch Int Med 152:1611-1616, Levine,P.H.,et al, 1992
National General Practice Study of Epilepsy:The Social & Psychological Effects of A Recent Diagnosis of Epilepsy
BMJ 304:1416-1418, Chaplin,J.E.,et al, 1992
Stroke Rehabilitation:Can We Do Better?
BMJ 305:1446-1447, Forster,A., 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Medical Assessment and Treatment of Chronic Epilepsy
BMJ 302:363-366, Shorvon,S.D., 1991
Clinicopath Conf
CA of Lung, DIC, Marantic Endocarditis, Multiple CVA's, Case 36-1991, NEJM 325:714-726., , 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991
The Chronic Fatigue Syndrome
Am J Med 90:730-739, Shafran,S.D., 1991
Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy and t-PA Treatment
Ann Neurol 29:210-213, Pendlebury,W.W.,et al, 1991
Concussion in Sports, Guidelines for the Prevention of Catastrophic Outcome
JAMA 266:2867-2869, Kelly,J.P.,et al, 1991
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis) An Update
Ann Int Med 113:39-52, Mulvihill,J.J.,et al, 1990
Practice Guidelines:Neurologic Evaluation
Neurol 40:871, , 1990
Control of Defecation in Patients with Spinal Injuries by Stimulation of Sacral Anterior Nerve Roots
BMJ 300:1494-1497, MacDonagh,R.P.,et al, 1990
Guillain-Barre Syndrome After Streptokinase Therapy
Acta Neurologica Scand 82:153, Roquer,J.,et al, 1990
Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990